62001-29-0

Basic information

• Product Name: N-PHENYLBENZOTRIAZOLEMETHANAMINE
• Synonyms: N-PHENYLBENZOTRIAZOLEMETHANAMINE, MIXTUR E OF BT1 AND BT2 ISOMERS;N-(benzotriazol-1-ylmethyl)aniline
• CAS NO: 62001-29-0
• Molecular Formula: C₁₃H₁₂N₄
• Molecular Weight: 224.26
• Mol File: 62001-29-0.mol
• Article Data: 6

Chemical Properties

• Melting Point: 137-143 °C(lit.)
• Appearance: /
• CAS DataBase Reference: N-PHENYLBENZOTRIAZOLEMETHANAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: N-PHENYLBENZOTRIAZOLEMETHANAMINE(62001-29-0)
• EPA Substance Registry System: N-PHENYLBENZOTRIAZOLEMETHANAMINE(62001-29-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 62001-29-0(Hazardous Substances Data)

Upstream product

• 95-14-7 1,2,3-Benzotriazole 
• 50-00-0 formaldehyd 
• 62-53-3 aniline 
• 28539-02-8 1-Hydroxymethyl-1H-benzotriazole 

Downstream Products

• 2655-27-8 N-pentylaniline 
• 95-14-7 1,2,3-Benzotriazole 
• 23117-65-9 2-[(phenylamino)methyl]cyclohexanone 
• 1212073-07-8 1,7,7-trimethyl-3-(phenylaminomethyl)-bicyclo(2.2.1)heptan-2-one 
• 127865-12-7 3,4-dihydro-2-(phenylaminomethyl)-1-naphthalenone 
• 127865-21-8 3,4-dihydro-2-bis(phenylaminomethyl)-1-naphthalenone 
• 101-77-9 4,4'-diamino diphenyl methane 
• 2983-48-4 1-phenyl-3-(phenylamino)propan-1-one 
• 130474-01-0 2-Phenylaminomethyl-hexanoic acid ethyl ester 
• 130473-94-8 2-Phenyl-3-phenylamino-propionic acid ethyl ester 
• 5448-31-7 N-(2-methyl-2-nitropropyl)aniline 
• 129075-89-4 4-[(benzotriazol-1-yl)methyl]phenylamine 
• 29369-71-9 N-(3-butenyl)aniline 
• 90921-20-3 allenylmethylaniline 

Relevant articles and documents

Design, synthesis, and biological evaluation of novel 4,4-difluoro-1-methyl-N, 6-diphenyl-5, 6-dihydro-4H-pyrimido [4, 5-b] [1, 2, 4] triazolo [4, 3-d] [1, 4] diazepin-8-amine derivatives as potential BRD4 inhibitors

Bromodomain-containing protein 4 (BRD4) plays an extremely important physiological role in cancer, and the BRD4 inhibitors can effectively inhibit the proliferation of tumor cells. By taking BI-2536 (PLK1 and BRD4 inhibitor) as the lead compound, sixteen

RSK2 benzo triazole derivatives as inhibitors of synthesis and use

The invention relates to synthesis of a benzotriazol derivative and its application, specifically to a compound as shown in the following formula II, a pharmaceutical composition containing the compound as shown in the formula II and an application of the compound in preparation of drugs for treating or preventing RSK2-mediated diseases.

Simple and convenient preparation of 1-(arylamino)methylbenzotriazoles and -(arylamino)methylbenzimidazoles

The preparation of 1-(arylamino)methylbenzotriazoles 1a-17a and benzimidazoles 1b-17b is described and their antibacterial activity evaluated. 1-Hydroxymethylbenzazoles react with the appropriate aniline to yield the target compounds. These were characterized using 1H NMR, IR, UV spectra. The compounds displayed no significant antibacterial activity.